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Background: Myocardial infarct heterogeneity indices including peri-infarct gray zone are predictors for
spontaneous ventricular arrhythmias events after ICD implantation in patients with ischemic heart disease. In this
study we hypothesize that the extent of peri-infarct gray zone and papillary muscle infarct scores determined by a
new multi-contrast late enhancement (MCLE) method may predict appropriate ICD therapy in patients with
ischemic heart disease.
Methods: The cardiovascular magnetic resonance (CMR) protocol included LV functional parameter assessment and
late gadolinium enhancement (LGE) CMR using the conventional method and MCLE post-contrast. The proportion
of peri-infarct gray zone, core infarct, total infarct relative to LV myocardium mass, papillary muscle infarct scores,
and LV functional parameters were statistically compared between groups with and without appropriate ICD
therapy during follow-up.
Results: Twenty-five patients with prior myocardial infarct for planned ICD implantation (age 64±10 yrs, 88% men,
average LVEF 26.2±10.4%) were enrolled. All patients completed the CMR protocol and 6–46 months follow-up at
the ICD clinic. Twelve patients had at least one appropriate ICD therapy for ventricular arrhythmias at follow-up.
Only the proportion of gray zone measured with MCLE and papillary muscle infarct scores demonstrated a
statistically significant difference (P < 0.05) between patients with and without appropriate ICD therapy for
ventricular arrhythmias; other CMR derived parameters such as LVEF, core infarct and total infarct did not show a
statistically significant difference between these two groups.
Conclusions: Peri-infarct gray zone measurement using MCLE, compared to using conventional LGE-CMR, might be
more sensitive in predicting appropriate ICD therapy for ventricular arrhythmia events. Papillary muscle infarct
scores might have a specific role for predicting appropriate ICD therapy although the exact mechanism needs
further investigation.
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Sudden cardiac death is a major cause of mortality in pa-
tients with ischemic heart disease (IHD). This mortality
is partially attributable to malignant ventricular arrhyth-
mias (VA) after myocardial infarction (MI). These malig-
nant arrhythmias can be terminated by implantable
cardioverter-defibrillator (ICD) therapy. Currently, poor
left ventricular ejection fraction (LVEF) is the primary
index that is used to decide whether or not to implant
an ICD [1-6]. However, many patients with poor LVEF
may not benefit from the ICD implantation as the an-
nual firing rates are approximately 5% [1,5]. Thus a bet-
ter risk stratification strategy may help improve the
efficacy of ICD therapy.
Late gadolinium enhancement (LGE) cardiovascular
magnetic resonance (CMR) can identify infarct hetero-
geneity which may represent a critical substrate for
arrhythmogenesis in patients post MI [7-9]. Infarct het-
erogeneity indices including myocardial scar tissue and
peri-infarct gray zone (GZ) may have the potential to
correctly predict VA events after ICD implantation in
patients with ischemic or non-ischemic cardiomyopathy
[10-12]. These indices are determined by signal intensity
thresholds or the full-width half-maximum (FWHM)
method using conventional LGE-CMR [13-15]. Recently
a multi-contrast late enhancement (MCLE) technique
was developed to yield improved visualization of infarct
tissue including a better identification of papillary
muscle (PM) involvement with a potential of accurate
quantification of infarct heterogeneity [16-18]. Auto-
mated segmentation and classification of infarct hetero-
geneity can be realized using MCLE and thus a better
reproducibility might be achieved [19]. While PM in-
volvement is a recognized source of VA events in pa-
tients with IHD [20,21], the specific role of PM-MI in
the prediction of appropriate ICD therapy has not been
established yet. In this study, we hypothesize that the ex-
tent of peri-infarct GZ and PM-MI scores determined
by MCLE may have the potential to more accurately




The institutional research ethics board at Sunnybrook
approved the study protocol and informed consent was
obtained in all subjects. In this study twenty-five patients
with prior myocardial infarction referred to our institu-
tion for ICD implantation for primary or secondary pre-
vention were enrolled for a pre-implantation CMR
study. Patients with MR-incompatible implants such as
pacemakers, intra-cranial aneurysmal clips and other
contraindications for CMR were excluded from study.
After the CMR examination and ICD implantation, thepatients were followed up in an ICD clinic on a quarterly
basis.
CMR protocol and image analysis
The CMR protocol included LV functional parameter as-
sessment using steady-state free precession (SSFP), as
well as LGE-CMR using an inversion recovery fast gradi-
ent echo (IR-FGRE) and MCLE post double-dose Gd in-
jection [17-19]. All CMR studies were performed on a
1.5 T GE Signa HDx system (GE Healthcare, Milwaukee,
USA) with ECG gating and using an eight-channel
phased-array cardiac coil. First, a short-axis oblique
SSFP stack of slices covering the whole left ventricle
based on a 3-plane localizer sequence were acquired for
LV function assessment. Typical SSFP CMR parameters
were as follows: bandwidth (rBW) ±125 kHz, flip angle
45°, views per segment (VPS) 16, TR/TE 3.7/1.6 ms, field
of view (FOV) = 32 cm, image matrix = 256×192, and
slice thickness 8 mm. 20 phase-resolved images over the
whole cardiac cycle were acquired in a breath hold.
Post-contrast LGE-CMR images using IR-FGRE which
was usually performed first and followed by MCLE were
acquired 10–20 minutes after a double-dose intravenous
bolus injection of Gd-DTPA (Magnevist®, Bayer Inc.,
Canada; Equivalent to 0.2 mmol/kg) using the same
short-axis oblique localization as the SSFP LV function
study. Depending on the null point of normal myocar-
dium, the inversion time (TI) varied from 200 to 300 ms
in IR-FGRE. Typical IR-FGRE CMR parameters con-
sisted of the following: TR/TE 6.0/3.0 ms, rBW
±31.5 kHz, flip angle 20°, VPS 20, number of excitations
(NEX) 2. The delay time (TDEL) was chosen to yield
images in mid- to late diastolic phase. Approximately
20 heartbeats (18-second breath-holds on average) were
required to produce a single LGE-CMR image using IR-
FGRE. For MCLE, a segmented SSFP readout was used
following an inversion recovery pulse, providing 20 car-
diac phase-resolved images at different TIs [16]. The
MCLE pulse sequence took about 13 heartbeats to ac-
quire (one for the establishment of steady state, and the
rest 12 for data acquisitions over an average breath-hold
of 11 seconds). Typical CMR parameters for MCLE se-
quence were as follows: TR/TE 2.7/1.3 ms, rBW ±125 kHz,
flip angle 30°, VPS 16, TDEL 500 ms, and NEX 1. The
early recovery phase was also gated to diastole. The in-
plane resolution was ~1.5×1.5 mm and the through-plane
resolution was 8 mm for both LGE-CMR and SSFP pulse
sequences.
LV functional parameters of LVEF, LV volumes at end-
systolic (LVESV) and end-diastolic phase (LVEDV),
stroke volumes (SV) and LV mass at end-diastolic phase
were measured using CMR42 software (Circle Cardiovas-
cular Imaging, Calgary, Canada). Infarct heterogeneity
analysis of core MI and peri-infarct GZ in IR-FGRE used
Yang et al. Journal of Cardiovascular Magnetic Resonance 2013, 15:57 Page 3 of 8
http://www.jcmr-online.com/content/15/1/57a full-width half-maximum method [14,19]. Epicardial
and endocardial contours were manually drawn to seg-
ment pixels within the LV myocardium, and then a re-
gion of interest (ROI) was drawn in remote healthy
myocardium. The mean (Meanremote), peak (Peakremote),
and standard deviation (SDremote) of the signal intensities
within the remote region were calculated. The cut-off
values for the infarct core and peri-infarct GZ were ap-
plied using a FWHM approach with the following defini-
tions: SIcore > 0.5 * Peakinfarct and Peakremote < SIgz < 0.5 *
Peakinfarct, where Peakinfarct is the peak signal intensity of
all pixels in the infarct. Color mapping was used to dem-
onstrate the core MI (green color) and peri-infarct GZ
(yellow color, Figure 1). For MCLE, infarct heterogeneity
analysis on core MI and peri-infarct GZ used a semi-
automated data clustering algorithm and the details of
this algorithm are elucidated in the reference [19]. For a
succinct description, the signal intensity recovery based
on MCLE images at diastolic phases of varied TIs (usu-
ally 6–8 images with minimal cardiac motion) was used
to generate T1* and steady-state value maps. Using the
fuzzy C-means algorithms on a scatter plot of T1* and
steady state values, each voxel can be automatically char-
acterized as infarct, healthy myocardium, or blood, with
the fuzzy clustering algorithm identifying the probability
of each voxel belonging to the above three clusters. The
peri-infarct GZ was determined as the voxels of 25% to
75% probability belonging to infarct or healthy myocar-
dium. A color map (Figure 1) was produced to represent
the spatial distribution of blood pool (red color), coreFigure 1 IR-FGRE vs. MCLE peri-infarct GZ map. a: IR-FGRE image; b: Pe
f: Peri-infarct GZ map from MCLE: yellow color indicating peri-infarct GZ, gr
color indicating healthy myocardium.MI (green color), peri-infarct GZ (yellow color), and
healthy myocardium (blue color). Similar to IR-FGRE
analysis, isolated voxels within healthy myocardium clas-
sified as core MI or peri-infarct GZ (due to noise) were
manually removed and re-labeled as healthy tissue. The
extent of the core MI and peri-infarct GZ for each sub-
ject was expressed in grams of tissue and normalized to
LV myocardium mass for both IR-FGRE and MCLE
analysis.
The determination of peri-infarct GZ extent as well as
PM-MI was blinded from the results of ICD events. The
presence of PM involvement was considered if the fol-
lowing criteria were satisfied [18]: a) The increased sig-
nal intensity in PM was the same or similar to that of
adjacent hyper-enhanced infarct segments on LGE-CMR
images; b) The hyper-enhanced PM region was limited
to the PM area defined by pre-contrast SSFP images.
PM-MI score was determined to be 2, 1, or 0 if both of
PM, only one PM, or no PM involvement was identified
on LGE-CMR images using MCLE pulse sequence
where there was a higher detection rate of PM-MI than
in IR-FGRE data sets [18].
ICD events and statistical analysis
All patients received a single or dual ICD implantation
according to current clinical guidelines. All patients were
followed in an ICD clinic at intervals of 3 months and
more frequently (if device shocks were delivered) for 6–
46 months with a median follow-up of 30 months. The
ICD data for the relevant ventricular arrhythmic eventsri-infarct GZ map corresponding to a; c-e: 3 MCLE images at varied TI;
een color indicating core MI, red color indicating blood pool, and blue
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The primary outcome measure was appropriate ICD
therapy that was defined as shock for ventricular tachy-
cardia (VT), ventricular fibrillation (VF), or any ven-
tricular arrhythmic event identified as sustained VT or
VF. Appropriate ICD therapy in the present study refers
to an ICD event as that which was triggered for a single
rhythm episode regardless of the total number of actual
shocks that were needed for termination of tachycardia.
Categorical data are expressed as numbers (percent-
ages) and compared with a Fisher exact test. Continuous
variables are expressed as mean ± SD. The Student t-test
was used for the statistical analysis of the proportion of
peri-infarct GZ, core MI, total MI relative to LV myocar-
dium mass, PM-MI scores, and LV functional parame-
ters between groups with and without appropriate ICD
therapy at follow-up. A p value <0.05 was defined as
having a statistical significance.
Results
The detailed demographic characteristics are presented
in Table 1. All patients successfully completed the CMR
study protocol and had ICD implantation according to
existing guidelines and were followed at an ICD clinic
for 6–46 months with a median of 30 months. Forty-
eight percent of patients (12/25) had at least one appro-
priate ICD therapy for VF or sustained VT at follow-up.Table 1 Baseline patient characteristics and CMR LV function
Patient characteristics Total (n = 25) With ICD thera
Age, years old 63.9 ± 10.0 63.7 ±
Male 22 (88) 10 (83
Primary prevention 15 (60) 6 (50
NYHA functional class 1.48 ± 0.96 1.8 ± 1
Anti-arrhythmic 5 (20) 2 (16
Smoking 14 (56) 6 (50
Hypertension 19 (76) 10 (83
Diabetes 5 (20) 2 (16
Hyperlipidemia 22 (88) 11 (91
QRS duration (ms) 114.9 ± 29.0 120.7 ±
Left bundle-branch block 5 (20) 3 (27
CMR LV function
LV EF (%) 26.2±10.4 22.1 ±
LV ESV (ml) 179.6±81.1 203.5 ±
LV EDV (ml) 236.6±82.2 256.2 ±
LV SV (ml) 56.5±17.9 52.7 ± 1
LVM (g) 106.1±29.9 110.9 ±
Notes:
1. Continuous data are expressed as mean ± SD and categorical data as n (%).
2. CMR cardiovascular magnetic resonance, ICD Implantable cardioverter-defibrillato
end-systolic volume, SV stroke volume, EDV end-diastolic volume, LVM LV mass at e
3. P > 0.05 indicates no statistically significant difference between two groups.No cardiac death occurred during follow-up in the
present study.
The CMR image quality was acceptable in all 25 sub-
jects for quantitative analysis of LV function and infarct
heterogeneity such as core MI and peri-infarct GZ. The
comparison on LV functional parameters from groups
with and without appropriate ICD therapy was listed in
Table 1 as well. There was no statistically significant dif-
ference observed from these two groups on functional
parameters of LVEF, LVEDV, LVESV, SV and LVM al-
though there was a trend toward poorer LV systolic
function observed in patients with appropriate ICD
therapy.
Infarct heterogeneity measurements including the total
size of MI, core MI and peri-infarct GZ normalized to
LV mass from groups with and without appropriate ICD
therapy were listed on Table 2. There was no statistically
significant difference observed in CMR infarct hetero-
geneity indices of core MI and total extent of MI relative
to LV mass using either MCLE or IR-FGRE between
these two groups, although the core MI and total extent
of MI tended to be greater in subjects with appropriate
ICD therapy from both MCLE and IR-FGRE measure-
ments. However, the proportion of peri-infarct GZ rela-
tive to LV mass measured with MCLE as opposed to
that measured with IR-FGRE demonstrated a statistical
difference between subjects with and without appro-al parameters
py (N = 12) Without ICD therapy (N = 13) P value
9.3 64.2 ± 10.9 0.91
.3) 12 (92.3) 0.55
) 9 (69.2) 0.44
.0 1.2 ± 0.9 0.18
.7) 3 (23.1) 0.57
) 8 (61.5) 0.51
.3) 9 (69.2) 0.50
.7) 3 (23.1) 0.57
.7) 11 (84.6) 0.67
36.4 109.6 ± 20.2 0.35
.3) 2 (15.4) 0.50
8.5 30.1 ± 10.9 0.054
82.7 157.6 ± 76.2 0.16
82.2 218.4 ± 81.2 0.26
8.9 60.1 ± 17.0 0.31
34.8 101.6 ± 25.2 0.45
r, NYHA New York Heart Association, LV left ventricular, EF ejection fraction, ESV
nd-diastolic phase.
Table 2 CMR infarct heterogeneity measurements in subjects with and without ICD therapy
With ICD therapy (n = 12) Without ICD therapy (n = 13) P value
MCLE IR-FGRE MCLE IR-FGRE MCLE IR-FGRE
GZ/LVM (%) 14.8 ± 4.8 13.8 ± 5.1 11.2 ± 3.9 10.6 ± 5.1 0.046 0.14
Core MI/LVM (%) 25.8 ± 10.9 22.4 ± 9.9 19.6 ± 10.1 16.8 ± 10.9 0.15 0.19
Total MI/LVM (%) 40.6 ± 13.5 36.2 ± 14.8 30.9 ± 13.5 27.4 ± 15.8 0.08 0.16
Abbreviations: CMR cardiovascular magnetic resonance, ICD Implantable cardioverter-defibrillator, MCLE multi-contrast late enhancement, IR-FGRE inversion
recovery fast gradient echo, GZ peri-infarct gray zone, MI myocardial infarction, LVM LV mass at end-diastolic phase.
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PM-MI scores between groups with appropriate ICD
therapy (1.67±0.49) and without (1.00±0.93) at follow-up
demonstrated a statistically significant difference (p =
0.035). Figure 2 demonstrated such an example: a pa-
tient with ischemic heart disease and a greater amount
of peri-infarct GZ relative to LV mass (18.5%) plus the
presence of both PM involvements determined on
MCLE images had ICD shocks for sustained VT at
follow-up.
Discussion
ICD implantation has become a well-established therapy
in patients with poor LV systolic function post myocar-
dial infarction for primary prevention of sudden cardiac
death [2,22]. However, rates of appropriate ICD therapy
are generally low and searching for better markers to
stratify patients at low or high risks for development of
malignant VA is needed [5,23]. A recent study suggested
that LGE-CMR infarct assessment is superior to LVEF
for risk stratification as even in patients with low LVEF
(<30%) a minimal or no scarring indicated a low-risk co-
hort similar in risk to those patients with higher LVEF
(>30%) [24]. In the present study pre-selected for low
LVEF, no significant differences were noted between
CMR determined LV functional parameters from groups
with and without ICD therapy, indicating that LVEF and
LV EDV/ESV might not be highly sensitive markers in
predicting appropriate ICD therapies.
Conventional LGE-CMR derived infarct tissue hetero-
geneity indices demonstrate the potential to accuratelyFigure 2 A patient with ischemic heart disease demonstrating both P
determined by MCLE had ICD shocks for sustained VT at follow-up. a
clearly demonstrating both PM involvement; d: Peri-infarct GZ map from M
MI, red color indicating blood pool, and blue color indicating healthy myopredict VA events in patients post myocardial infarction
and might have a role in the triage of patients benefitting
the most from ICD implantation [24-29]. This study fur-
ther indicated that a new LGE-CMR (MCLE) derived
peri-infarct GZ extent might be a more sensitive maker
in the prediction of appropriate ICD therapy, compared
to indices derived from conventional LGE-CMR. Peri-
infarct GZ contains bundles of viable myocardium with
a mixture of fibrotic scar tissue, indicating that re-entry
routes for the slow electrical conduction might exist in
the inhomogeneous infarct tissue, and whole mount
histological techniques were attempted for validation
[30,31]. On LGE-CMR images it appears as increased
intermediate signal intensity (gray zone separating from
the low signal intensity of healthy myocardium and high
signal intensity of scar tissue) [19].
A higher sensitivity using MCLE in the identification
of peri-infarct GZ could be illustrated inherently in its
multi-contrast capability and the semi-automated data-
clustering algorithm applied [16-19]. MCLE uses SSFP
readout immediately after an inversion pulse, which per-
mits visualization of infarction as an area of fast T1 re-
covery with the simultaneous nulling of blood pool and
viable myocardium. The improved differentiation with
multi-contrast among healthy myocardium, infarct and
blood pool provides better identification of infarct het-
erogeneity. The use of semi-automated data-clustering
algorithm may provide a more reproducible measure-
ment of infarct heterogeneity, compared to other seg-
mentation algorithms which frequently require manual
contouring and arbitrary selection of ROIs in the remoteM involvement and a greater peri-infarct GZ of 18.5%
: IR-FGRE image showing one PM involvement; b-c: MCLE images
CLE: yellow color indicating peri-infarct GZ, green color indicating core
cardium.
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variation [32]. In this prospective study the extent of
total MI and core MI did not achieve a statistical signifi-
cance in the prediction of appropriate ICD therapy even
using MCLE-based algorithms, probably due to the
small sample size. However, in larger sample studies the
extent of MI is a validated predictor for appropriate ICD
shocks in patients with ischemic cardiomyopathy [24].
MCLE also provides better identification of PM in-
volvement in patients with myocardial infarction [18].
This specific involvement is a recognized source of VA
and surgical resection or ablation of scarred papillary
muscle can eliminate ventricular arrhythmias [33,34].
This study demonstrated that PM-MI scores might have
a specific role in the prediction of appropriate ICD ther-
apy, although the exact mechanism warrants further ex-
ploration. PM-MI might indicate the existence of more
inhomogeneous infarct tissue or a tendency of yielding a
critical isthmus between scar tissues of LV free wall and
papillary muscles. The efforts on identifying possible
critical isthmuses have been reported using color overlay
conventional LGE-CMR images [35,36]. These possible
critical isthmuses might appear as distinguished chan-
nels of heterogeneous tissue corridors and were likely
sites of slow conduction properties and the causes of VT
events. As a large portion of PM are within LV cavity
and attached to LV wall as a part of mitral apparatus
[37], this morphology might provide the anatomic basis
for more heterogeneous corridors existing between
dense scar tissues of LV free wall and PM-MI, thus
prompting the generation of malignant VA. In the rou-
tine analysis of infarct heterogeneity, the PM is often ex-
cluded as a portion of myocardium due to the time
consuming effort needed to trace these structures or be-
cause of the poor delineation on conventional LGE-
CMR using IR-FGRE techniques; thus the role of PM in-
volvement in the prediction of adequate ICD therapy or
worse outcome might be overlooked. The present study
demonstrated that the improved detection of PM in-
volvement in patients with prior MI using the MCLE
pulse sequence might provide a new parameter of PM-MI
scores in the risk stratification of adequate ICD implant-
ation or for guiding the ablation of VT which originate
from scarred papillary muscles.
There are several limitations to this study. First, this is
a small sample study for testing the hypothesis that
MCLE determined infarct heterogeneity indices might
be more sensitive than conventional LGE-CMR in the
prediction of ICD therapy in patients with ischemic
heart disease. Due to the small sample size, multi-
variable analysis was not feasible to determine which
specific index was a better marker. In this study the
higher ventricular arrhythmic episodes might be due to
a selection bias. Patients were mixed population forsecondary and primary prevention and had severe LV
systolic dysfunction with an average infarct size of
greater than 30% of LV mass indicating the existence of
severe myocardial damage, which potentially contributed
to the high ICD firing rates. Although this selection bias
may affect the number of episodes, it should not affect
their distribution between these two groups with or
without appropriate ICD therapy in our opinion. The
long period of follow-up (up to 4 years) might contribute
to the higher ventricular arrhythmic episodes in this
study as well.
Conclusion
In conclusion, peri-infarct gray zone measurement using
MCLE might be a more sensitive and reproducible par-
ameter in predicting appropriate ICD therapy for malig-
nant ventricular arrhythmias events, compared to using
conventional LGE-CMR. Papillary muscle involvement
scores might have a specific role in the prediction of appro-
priate ICD therapy as well although the exact mechanism
needs further investigation.
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